 | • レポートコード：MRC2012A0095 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アデノウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。アデノウイルスワクチンの種類別市場規模（4価ワクチン、７価ワクチン）、用途別市場規模（研究所＆学術研究所、製薬＆バイオテクノロジー産業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Teva Pharmaceuticals、Barr Labs、 ・地域別グローバル市場分析 2015年-2020年 ・アデノウイルスワクチンの北米市場（アメリカ、カナダ、メキシコ） ・アデノウイルスワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アデノウイルスワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アデノウイルスワクチンの南米市場（ブラジル、アルゼンチン） ・アデノウイルスワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：4価ワクチン、７価ワクチン ・用途別分析：研究所＆学術研究所、製薬＆バイオテクノロジー産業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Adenovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Adenovirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Adenovirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Adenovirus Vaccine market has been segmented into
Type 4 Vaccine
Type 7 Vaccine
By Application, Adenovirus Vaccine has been segmented into:
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adenovirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Adenovirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adenovirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Adenovirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Adenovirus Vaccine Market Share Analysis
Adenovirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Adenovirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adenovirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Adenovirus Vaccine are:
Teva Pharmaceuticals
Barr Labs
Among other players domestic and global, Adenovirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Adenovirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Adenovirus Vaccine, with price, sales, revenue and global market share of Adenovirus Vaccine in 2018 and 2019.
Chapter 3, the Adenovirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adenovirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Adenovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Adenovirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Adenovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adenovirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Type 4 Vaccine
1.2.3 Type 7 Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Adenovirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Overview of Global Adenovirus Vaccine Market
1.4.1 Global Adenovirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceuticals
2.1.1 Teva Pharmaceuticals Details
2.1.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceuticals SWOT Analysis
2.1.4 Teva Pharmaceuticals Product and Services
2.1.5 Teva Pharmaceuticals Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Barr Labs
2.2.1 Barr Labs Details
2.2.2 Barr Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Barr Labs SWOT Analysis
2.2.4 Barr Labs Product and Services
2.2.5 Barr Labs Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Adenovirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Adenovirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Adenovirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Adenovirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Adenovirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Adenovirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Adenovirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Adenovirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Adenovirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Adenovirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Adenovirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Adenovirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Adenovirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Adenovirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Adenovirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Adenovirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Adenovirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Adenovirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Adenovirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Adenovirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Adenovirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Adenovirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Adenovirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Adenovirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Adenovirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Adenovirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Adenovirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Adenovirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Adenovirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Adenovirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Adenovirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Adenovirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Adenovirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Adenovirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Adenovirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Adenovirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Adenovirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Adenovirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Adenovirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Adenovirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Adenovirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Adenovirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Adenovirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Adenovirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Adenovirus Vaccine Price by Type (2015-2020)
11 Global Adenovirus Vaccine Market Segment by Application
11.1 Global Adenovirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Adenovirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Adenovirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Adenovirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Adenovirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Adenovirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Adenovirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Adenovirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Adenovirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Adenovirus Vaccine Market Forecast (2021-2025)
12.3 Adenovirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Adenovirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Adenovirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Adenovirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Adenovirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Adenovirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Adenovirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Adenovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Adenovirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceuticals Adenovirus Vaccine Major Business
Table 9. Teva Pharmaceuticals Adenovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Teva Pharmaceuticals SWOT Analysis
Table 11. Teva Pharmaceuticals Adenovirus Vaccine Product and Services
Table 12. Teva Pharmaceuticals Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Barr Labs Basic Information, Manufacturing Base and Competitors
Table 14. Barr Labs Adenovirus Vaccine Major Business
Table 15. Barr Labs Adenovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Barr Labs SWOT Analysis
Table 17. Barr Labs Adenovirus Vaccine Product and Services
Table 18. Barr Labs Adenovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Adenovirus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Adenovirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Adenovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 22. Global Adenovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 23. Global Adenovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Adenovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 25. North America Adenovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 26. North America Adenovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Adenovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 28. Europe Adenovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 29. Europe Adenovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 30. Europe Adenovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Adenovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Adenovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Adenovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Adenovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. South America Adenovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 36. South America Adenovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Adenovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Adenovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Adenovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Adenovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Adenovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 42. Global Adenovirus Vaccine Sales by Type (2015-2020) (K Units)
Table 43. Global Adenovirus Vaccine Sales Share by Type (2015-2020)
Table 44. Global Adenovirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 45. Global Adenovirus Vaccine Revenue Share by Type (2015-2020)
Table 46. Global Adenovirus Vaccine Sales by Application (2015-2020) (K Units)
Table 47. Global Adenovirus Vaccine Sales Share by Application (2015-2020)
Table 48. Global Adenovirus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Adenovirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 50. Global Adenovirus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Adenovirus Vaccine Market Share Forecast by Type (2021-2025)
Table 52. Global Adenovirus Vaccine Sales Forecast by Application (2021-2025)
Table 53. Global Adenovirus Vaccine Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Adenovirus Vaccine Picture
Figure 2. Global Sales Market Share of Adenovirus Vaccine by Type in 2019
Figure 3. Type 4 Vaccine Picture
Figure 4. Type 7 Vaccine Picture
Figure 5. Adenovirus Vaccine Sales Market Share by Application in 2018
Figure 6. Research & Academic Laboratories Picture
Figure 7. Pharmaceutical & Biotechnology Companies Picture
Figure 8. Others Picture
Figure 9. Global Adenovirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Adenovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Adenovirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Adenovirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Adenovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Adenovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Adenovirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Adenovirus Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Adenovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Adenovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Adenovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Adenovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Adenovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Adenovirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Adenovirus Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Adenovirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Adenovirus Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Adenovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Adenovirus Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Adenovirus Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Adenovirus Vaccine Revenue Market Share by Regions 2019
Figure 62. China Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Adenovirus Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Adenovirus Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Adenovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Adenovirus Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Adenovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Adenovirus Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Adenovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Adenovirus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Adenovirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Adenovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Adenovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Adenovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Adenovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Adenovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…- 経口コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cholera Vaccine mar…
- 髄膜炎菌グループBワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Meningococcal Group B Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococcal G…
- 腸チフスVi多糖ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Typhoid Vi Polysaccharide Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Typhoid Vi …
- 腸チフスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Typhoid Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Typhoid Vaccine market report…